Foresite Capital Management Ii Llc decreased its stake in Acceleron Pharma Inc. (XLRN) by 4.84% based on its latest 2018Q4 regulatory filing with the SEC. Foresite Capital Management Ii Llc sold 10,666 shares as the company’s stock declined 13.57% while stock markets rallied.